MyMD Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Basis of Presentation and Significant Accounting Policies (Polices)
Notes Tables
Notes Details

Major Suppliers

Major Suppliers	3 Months Ended
Mar. 31, 2016
Major Suppliers [Abstract]
Major Suppliers	Note 15 Major Suppliers For the three months ended March 31, 2016, two suppliers each accounted for more than 10% of the Companys purchases. In aggregate, these suppliers accounted for 23% of the Companys total purchases. As of March 31, 2016, the amount due to the suppliers was $-. This concentration makes the Company vulnerable to a near-term severe impact should the relationships be terminated. For the three months ended March 31, 2015, two suppliers each accounted for more than 10% of the Companys purchases. These suppliers accounted for 45% of the Companys total purchases.

Major Suppliers

3 Months Ended

Mar. 31, 2016

Major Suppliers [Abstract]

Major Suppliers

Note 15 Major Suppliers

For the three months ended March 31, 2016, two suppliers each accounted for more than 10% of the Companys purchases. In aggregate, these suppliers accounted for 23% of the Companys total purchases. As of March 31, 2016, the amount due to the suppliers was $-. This concentration makes the Company vulnerable to a near-term severe impact should the relationships be terminated.

For the three months ended March 31, 2015, two suppliers each accounted for more than 10% of the Companys purchases. These suppliers accounted for 45% of the Companys total purchases.